1. Home
  2. NVCR vs MLNK Comparison

NVCR vs MLNK Comparison

Compare NVCR & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • MLNK
  • Stock Information
  • Founded
  • NVCR 2000
  • MLNK 1998
  • Country
  • NVCR Switzerland
  • MLNK United States
  • Employees
  • NVCR N/A
  • MLNK N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • MLNK Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • MLNK Technology
  • Exchange
  • NVCR Nasdaq
  • MLNK Nasdaq
  • Market Cap
  • NVCR 1.4B
  • MLNK 1.3B
  • IPO Year
  • NVCR 2015
  • MLNK 2021
  • Fundamental
  • Price
  • NVCR $12.43
  • MLNK $19.87
  • Analyst Decision
  • NVCR Buy
  • MLNK Hold
  • Analyst Count
  • NVCR 7
  • MLNK 8
  • Target Price
  • NVCR $28.79
  • MLNK $21.21
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • MLNK 1.4M
  • Earning Date
  • NVCR 07-24-2025
  • MLNK 08-11-2025
  • Dividend Yield
  • NVCR N/A
  • MLNK N/A
  • EPS Growth
  • NVCR N/A
  • MLNK N/A
  • EPS
  • NVCR N/A
  • MLNK N/A
  • Revenue
  • NVCR $630,160,000.00
  • MLNK $325,891,000.00
  • Revenue This Year
  • NVCR $6.68
  • MLNK $6.21
  • Revenue Next Year
  • NVCR $7.01
  • MLNK $5.66
  • P/E Ratio
  • NVCR N/A
  • MLNK N/A
  • Revenue Growth
  • NVCR 14.58
  • MLNK 5.96
  • 52 Week Low
  • NVCR $10.87
  • MLNK $15.49
  • 52 Week High
  • NVCR $34.13
  • MLNK $25.33
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 46.30
  • MLNK 75.19
  • Support Level
  • NVCR $11.55
  • MLNK $19.79
  • Resistance Level
  • NVCR $12.26
  • MLNK $19.85
  • Average True Range (ATR)
  • NVCR 0.46
  • MLNK 0.18
  • MACD
  • NVCR 0.30
  • MLNK 0.20
  • Stochastic Oscillator
  • NVCR 97.50
  • MLNK 98.81

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About MLNK MeridianLink Inc.

MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.

Share on Social Networks: